Rare Tumors

Scope & Guideline

Innovating research for uncommon neoplasms.

Introduction

Immerse yourself in the scholarly insights of Rare Tumors with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2036-3605
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 2010 to 2024
AbbreviationRARE TUMORS / Rare Tumors
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Rare Tumors' focuses on the publication of original research and case reports that delve into the unique characteristics, management strategies, and outcomes of rare tumors across various demographics. It aims to foster knowledge and understanding of less common malignancies, providing a platform for sharing clinical experiences that can influence treatment approaches and improve patient outcomes.
  1. Clinical Characteristics and Outcomes:
    The journal emphasizes the clinical presentation, characteristics, and treatment outcomes of rare tumors, providing insights that can guide clinical practice and improve patient management.
  2. Case Reports and Literature Reviews:
    A significant portion of the journal is dedicated to detailed case reports and literature reviews, which highlight unique and rare tumor presentations, diagnostic challenges, and therapeutic approaches.
  3. Multidisciplinary Approaches to Rare Tumors:
    The journal encourages discussions on multidisciplinary treatment strategies involving surgery, chemotherapy, radiation, and emerging therapies for managing rare tumors.
  4. Emerging Therapies and Innovations:
    It explores novel therapeutic options and advancements in the management of rare tumors, including the use of immunotherapies and targeted therapies.
  5. Global Perspectives on Rare Tumors:
    The journal features studies from various geographical locations, allowing for a broader understanding of rare tumors in diverse populations and healthcare settings.
Recent publications in 'Rare Tumors' have highlighted a number of trending and emerging themes that reflect the evolving landscape of rare tumor research. These themes indicate a shift towards more personalized medicine, innovative therapies, and comprehensive patient management strategies.
  1. Innovative Immunotherapies:
    There is a growing emphasis on the exploration of immunotherapy as a treatment modality for various rare tumors, reflecting a broader trend in oncology towards personalized and targeted treatment options.
  2. Psychosocial and Quality of Life Studies:
    Recent papers are increasingly addressing the psychosocial aspects and quality of life of patients with rare tumors, highlighting the importance of holistic patient care beyond just clinical outcomes.
  3. Multidisciplinary Treatment Approaches:
    The trend towards collaborative, multidisciplinary treatment strategies is evident, with more studies focusing on how combined efforts from different specialties can enhance patient outcomes for rare tumors.
  4. Genetic and Molecular Characterization:
    There is an emerging focus on the genetic and molecular profiling of rare tumors, contributing to a better understanding of tumor behavior and potential targeted therapies.
  5. Global Health Perspectives:
    An increase in studies that consider global health perspectives on rare tumors, including case reports from diverse geographical regions, is evident, promoting a more inclusive understanding of these malignancies.

Declining or Waning

While 'Rare Tumors' continues to focus on various aspects of rare malignancies, certain themes have shown a decline in prominence over recent years. These waning areas may reflect shifts in research priorities or the consolidation of knowledge in previously underexplored topics.
  1. General Tumor Biology Studies:
    There has been a noticeable decrease in publications focusing solely on the basic biology of rare tumors, as the journal shifts towards more clinically relevant case studies and treatment outcomes.
  2. Traditional Chemotherapy Protocols:
    The frequency of papers discussing traditional chemotherapy protocols for rare tumors is declining, possibly due to the rise of targeted therapies and immunotherapies that are gaining prominence in treatment discussions.
  3. Epidemiological Studies of Rare Tumors:
    Fewer epidemiological studies are being published, suggesting a waning interest in the statistical analysis of rare tumor incidence and prevalence, which may have been overshadowed by more pressing clinical insights and therapeutic innovations.

Similar Journals

Journal of Bone Oncology

Connecting Knowledge for Better Bone Oncology Outcomes
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Journal of Bone Oncology, published by ELSEVIER, is a pivotal open access journal that has been advancing the field of oncology since its inception in 2012. Focused on the intricate relationship between bone-related malignancies and therapeutic advancements, this journal addresses critical issues in bone oncology, including novel treatments, diagnostic methodologies, and translational research. With a commendable impact factor reflecting its scholarly contributions and ranking in the Q2 category of oncology journals (2023), the Journal of Bone Oncology is recognized within the top 67th percentile across Scopus rankings, showcasing its relevance and quality in the medical oncology landscape. Available in open access, the journal promotes widespread dissemination of knowledge, ensuring that researchers, professionals, and students can access groundbreaking research that informs clinical practices and enhances patient outcomes. Located in Germany and targeting a global audience, the journal’s wealth of resources serves as an essential platform for fostering collaboration and innovation in the oncology community.

Case Reports in Oncological Medicine

Elevating patient care with detailed case studies.
Publisher: HINDAWI LTDISSN: 2090-6706Frequency: 1 issue/year

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

Gastrointestinal Tumors

Empowering Research for a Healthier Tomorrow
Publisher: KARGERISSN: 2296-3774Frequency: 4 issues/year

Gastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.

Oxford Medical Case Reports

Unveiling the complexities of infectious diseases, one case at a time.
Publisher: OXFORD UNIV PRESSISSN: 2053-8855Frequency: 12 issues/year

Oxford Medical Case Reports is a pivotal open-access journal published by Oxford University Press that has been a significant contributor to the field of medical literature since its inception in 2014. With an ISSN of 2053-8855, this journal aims to disseminate case reports that enhance the understanding of infectious diseases, microbiology, and parasitology. While currently positioned in the Q4 quartile in these fields, the journal is dedicated to presenting unique clinical insights that not only foster professional development but also support the educational needs of students and emerging researchers. Its open-access model ensures that vital research is accessible to a global audience, facilitating knowledge sharing and collaboration across disciplines. With an ambition to improve its rankings and a vision to expand its impact on medical practice, Oxford Medical Case Reports stands as a valuable resource for healthcare professionals striving to stay informed about the latest case-based advancements in their fields.

Endocrinology Diabetes and Metabolism Case Reports

Transforming Complex Cases into Clinical Solutions
Publisher: BIOSCIENTIFICA LTDISSN: Frequency: 1 issue/year

Endocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.

Case Reports in Endocrinology

Unlocking the stories behind hormone-related conditions.
Publisher: HINDAWI LTDISSN: 2090-6501Frequency:

Case Reports in Endocrinology is a pioneering open access journal published by HINDAWI LTD, dedicated to advancing the field of endocrinology through the publication of case reports that illuminate the complexities of hormone-related disorders and metabolic issues. With its ISSN 2090-6501 and E-ISSN 2090-651X, the journal has been accessible since 2011, inviting contributions from researchers, clinicians, and students worldwide. Based in the United States, Case Reports in Endocrinology aims to disseminate critical insights and unique case analyses that contribute to the broader understanding of endocrinological conditions. While currently ranked Q4 in Endocrinology, Diabetes, and Metabolism, with Scopus placing it in the 29th percentile, the journal strives to enhance its impact and visibility. By fostering an environment for knowledge sharing and collaboration in a rapidly evolving field, this journal serves as an essential resource for those looking to deepen their understanding of endocrinological complexities and improve clinical practices.

International Cancer Conference Journal

Leading the Charge Against Cancer Through Knowledge
Publisher: SPRINGER INT PUBL AGISSN: 2192-3183Frequency: 4 issues/year

International Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.

AME Case Reports

Elevating Healthcare Standards Through Peer-Reviewed Cases
Publisher: AME PUBLISHING COMPANYISSN: 2523-1995Frequency: 4 issues/year

AME Case Reports, published by AME PUBLISHING COMPANY, is a peer-reviewed open-access journal dedicated to the dissemination of high-quality clinical case reports across various medical disciplines. With an expanding focus on innovative medical practices and clinical experiences, this journal serves as an essential platform for healthcare professionals, researchers, and medical students to share significant findings and insights that contribute to evidence-based practices. Although specific metrics such as impact factors and H-index are not currently available, the journal's commitment to academic rigor and accessibility fosters an environment for scholarly exchange and professional development. The publication facilitates immediate access to important case studies that may inform clinical decisions and improve patient care. In an era where sharing specialized knowledge is paramount, AME Case Reports stands as a vital resource for those involved in the medical community worldwide.

Acta Oto-Laryngologica Case Reports

Fostering Collaboration in Otolaryngology with Open Access Insights
Publisher: TAYLOR & FRANCIS LTDISSN: 2377-2484Frequency: 1 issue/year

Acta Oto-Laryngologica Case Reports, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to the dissemination of high-quality case reports in the field of otolaryngology. Since its inception in 2016, this journal has been a vital platform for researchers and clinicians to share unique clinical insights and advancements related to ear, nose, and throat disorders. With an ISSN of 2377-2484, it provides unparalleled access to the latest findings, facilitating collaboration and innovation among professionals in otolaryngology. The journal's commitment to open-access publishing ensures that critical research is freely available to a global audience, enhancing the visibility and impact of its contributors' work. Researchers, practitioners, and students in the medical field will find valuable resources and case studies that not only contribute to professional development but also address current challenges in patient care.

Molecular and Clinical Oncology

Advancing cancer research for a healthier tomorrow.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.